HEROSTEM BIOTECHNOLOGY

HEROSTEM BIOTECHNOLOGY

Biotech firm specializing in stem cell research and clinical applications, integrating advanced techniques for stem cell separation and expansion. Learn more

Launch date
Changchun Jilin (HQ)
  • Edit
DateInvestorsAmountRound

$2.3m

Series A
Total Funding$2.3m

Recent News about HEROSTEM BIOTECHNOLOGY

Edit
More about HEROSTEM BIOTECHNOLOGYinfo icon
Edit

The Melting Biotech Company of Jilin Province, located in Changchun City, is a leading biotech firm specializing in stem cell research and clinical applications. The company brings together professionals with extensive experience in both basic stem cell research and clinical applications. It integrates advanced domestic and international techniques for the separation, screening, and expansion of stem cells derived from embryos, envelopes, umbilical cords, umbilical blood, and fatty tissues. The stem cells used are a specific type derived from early adult tissue, typically at 8 to 12 weeks of development, making them some of the earliest stage stem cells that can be extracted today. The company serves clients in the medical and biotech industries, focusing on innovative solutions for regenerative medicine and therapeutic applications. Its business model revolves around providing cutting-edge stem cell products and services, generating revenue through research collaborations, clinical trials, and the commercialization of stem cell-based therapies.

Keywords: stem cell research, clinical applications, biotech, regenerative medicine, umbilical cord blood, embryo stem cells, tissue expansion, therapeutic solutions, medical innovation, Changchun City.